Sponsored by:

Molecular Imaging

FDG-PET/CT predicts outcomes in patients with HCC
By Will Morton
Elevated FDG uptake was consistently associated with poorer overall survival.
May 22, 2026
A graphical abstract of the study.
BAMF Health highlights first dosing of Lu-177 BetaBart radiotherapeutic
By AuntMinnie.com staff writers
Treatment marks milestone in theranostics joint venture.
May 22, 2026
Atom Nuclear Lab Thumb
Radnostix reports 27% revenue decline in Q1
By AuntMinnie.com staff writers
Radnostix reported a 27% decrease in the first quarter of 2026 compared to the previous year's first quarter.
May 21, 2026
Research Money 400
GEHC, UW Medicine Radiology launch imaging collaboration
By AuntMinnie.com staff writers
GEHC and the UW Department of Radiology are collaborating to advance CT and molecular imaging technologies.
May 21, 2026
Ge Health Care Logo
Niowave breaks ground on $75M Mich. Ac-225 production facility
By AuntMinnie.com staff writers
Niowave has broken ground on its Ac-225 production facility in Lansing, MI, with construction expected to be finished by 2028.
May 21, 2026
Construction Pharmaceutical Manufacturing 400
NRC to ease burden on radiopharmaceutical licensees
By AuntMinnie.com staff writers
The rule would eliminates decommissioning financial assurance (DFA) for all radionuclides with half-lives of 120 days or less.
May 19, 2026
Isotopes1
Plus Therapeutics inks AI deal with Ephemeral Technologies
By AuntMinnie.com staff writers
Plus Therapeutics is a clinical-stage pharmaceutical company developing radiopharmaceutical therapies for CNS cancers.
May 19, 2026
Ai Handshake
Quantum BioPharma reports early results from MS PET imaging study
By AuntMinnie.com staff writers
If validated, the imaging approach could be used to measure how therapies affect myelin preservation and regeneration.
May 18, 2026
Pet Brain
ISMRM: PET/MRI-guided treatment reduces low back pain
By Will Morton
This study is the first to acquire follow-up FDG-PET/MRI scans after treatment to assess the correlation between clinical outcome and FDG uptake.
May 15, 2026
A 70-year-old female patient with chronic low back pain. History of radicular syndrome which led to targeted nerve block with positive effect. However, lower back pain persisted. FDG-PET/MRI showed increased FDG uptake in a disc herniation at L5-S1 (SUVmax 1.6) convincing the treating physician to proceed to discectomy. After discectomy, the patient is now mostly pain free.
SNMMI highlights new radiopharmaceutical therapy
By AuntMinnie.com staff writers
Mice bearing PDAC xenografts received lutetium-177 (Lu-177) AKIR001, a radiopharmaceutical that targets CD44v6.
May 13, 2026
Biodistribution of Lu-177 AKIR001. (A) Mice (N = 12) bearing BxPC3 tumors were injected with Lu-177 AKIR001 and dissected at 24 (N = 4), 96 (N = 4), and 168 hours (N = 4) postinjection. Error bars represent SD. (B) Representative SPECT/CT images at 96 hours postinjection. GI = gastrointestinal.
Bayer issues positive report for cardiac amyloidosis radiotracer
By AuntMinnie.com staff writers
I-124 evuzamitide met its primary endpoints, according to Bayer.
May 7, 2026
Bayer w6 My4 Ipr De
PSMA-PET linked to higher use of systemic therapies
By Will Morton
ARPI therapy was initiated in 15.6% of PSMA-PET patients versus 7.7% of bone scan patients.
May 7, 2026
Psma Pet
Page 1 of 626
Next Page